Literature DB >> 3168334

Vitiligo.

J A Kenney1.   

Abstract

Vitiligo is a disease that affects from 1 to 3 per cent of the population. It is characterized by cutaneous white macules that often develop in cosmetically important areas such as the face, the dorsal hands, and the arms. It may be accompanied by ocular abnormalities and a number of associated disorders such as thyroid disease, diabetes, pernicious anemia, and alopecia areata. There is increasing evidence that vitiligo is an autoimmune disease. Although there is as yet no definitive cure, many patients have obtained respectable repigmentation by the use of topical or oral psoralen plus ultraviolet light. When large areas of skin are involved or when the patient is unresponsive to therapy, serious consideration should be given to depigmentation with monobenzone (Benoquin).

Entities:  

Mesh:

Year:  1988        PMID: 3168334

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  2 in total

1.  Abnormal sympathetic skin response in patients with autoimmune vitiligo and primary autoimmune hypothyroidism.

Authors:  M Merello; M Nogues; R Leiguarda; C López Saubidet; A Florin
Journal:  J Neurol       Date:  1993-02       Impact factor: 4.849

2.  Efficacy of suction blister epidermal grafting with concomitant phototherapy in vitiligo treatment.

Authors:  Tomasz Iwanowski; Piotr Szlązak; Alicja Rustowska; Małgorzata Sokołowska-Wojdyło
Journal:  Postepy Dermatol Alergol       Date:  2018-11-08       Impact factor: 1.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.